ARAlicia Ramírez-Ramírez

Alicia Ramírez-Ramírez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alicia Ramírez-Ramírez has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Expression of CD64 and CD69 as biomarkers for late-onset sepsis diagnosis in infants born prematurely

    by Alicia Ramírez-Ramírez, Ismael Mancilla-Herrera, Ricardo Figueroa-Damián, Diana Mercedes Soriano-Becerril, Graciela Villeda-Gabriel


  • Open Access

    Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method

    by Alicia Ramírez-Ramírez, Elías Sánchez-Serrano, Giselle Loaiza-Flores, Noemí Plazola-Camacho, Rosa Georgina Rodríguez-Delgado, Ricardo Figueroa-Damián, Mauricio Domínguez-Castro, Margarita López-Martínez, Zayra Flores-García, Jessica Hernández-Pineda

    The primary strategy to avoid mother-to-child transmission of human immunodeficiency virus (HIV) through breastfeeding is administration of highly active antiretroviral therapy (HAART) to HIV-positive pregnant women. Because significant changes in the pharmacokinetics of antiretroviral (ARV) drugs occur during pregnancy, quantifying HAART and the viral load in breast milk in this population is essential. Here, we developed an analytical assay for the simultaneous quantification of four ARV drugs in breast milk using ultra-performance liquid chromatography coupled to tandem mass spectrometry. We validated this method following Mexican and international guidelines. ARV drugs. We extracted the ARV drugs from 200 μL samples of breast milk and detected these drugs in a triple quadrupole mass spectrometer with positive electrospray ionization. The validated concentration ranges (ng/mL) for zidovudine, lamivudine, lopinavir, and ritonavir were 12.5–750, 50–2500, 100–5000 and 5 to 250, respectively. Additionally, the absolute recovery percentages (and matrix effects) were 91.4 (8.39), 88.78 (28.75), 91.38 (11.77) and 89.78 (12.37), respectively. We determined that ARV drugs are stable for 24 h at 8°C and 24°C for 15 days at –80°C. This methodology had the capacity for simultaneous detection; separation; and accurate, precise quantification of ARV drugs in human breast milk samples according to Mexican standard laws and United States Food and Drug Administration guidelines.


  • Open Access

    NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis

    by Mirsha Pamela Hernández-Rivera, Alicia Ramírez-Ramírez, Adelaido Chiñas-Pérez, Amalia Monroy-Ostria, Mario Eugenio Cancino-Díaz, Omar Hernández-Montes

    Cutaneous leishmaniasis (CL) is endemic in Campeche state, Mexico. Host and parasite factors are involved in the establishment and development of CL. Host factors include immune response and genetic background. NRAMP1 (Natural Resistance Associated Macrophage Protein 1) is important in innate immunity. Polymorphisms inNRAMP1have been associated with susceptibility or resistance to infectious and autoimmune diseases. To study the association ofNRAMP1mutations with CL in patients from Calakmul, Campeche, samples from 115 CL patients and 69 samples of healthy people from the same area were evaluated. Five regions inNRAMP1were amplified and digested, looking for mutations in the promoter region (−524G/C), exon 3 (274C/T), exon 8 (823 C7T), and exon 15 (G/A) and deletion of 4 bp in the 3′UTR region. We found a statistical association between polymorphisms in 3′UTR region and exon 8 and CL [χ2=13.26;p<0.05; OR = 17.00; IC of 95% (2.24–128.99)]. Some patients who needed more than 40 doses of Glucantime®to heal injuries presented mutations in exons 3, 8, and 15. Multiple or ear lesions were not associated withNRAMP1polymorphism.


  • Immune Function in Pregnant Women with Affective Disorders

    by Norma Galindo-Sevilla, Philippe Leff Gelman, Carlos Cruz Fuentes, Armando Cordova Barrios, Javier Mancilla-Ramirez, Alicia Ramírez-Ramírez, Monica Flores-Ramos

    Perinatal depression is an emerging field with questions that remain to be answered, including the underlying pathogenesis, treatment and counseling. Pregnant women with depression represent a serious risk to themselves due to negative fetal/obstetrical and neonatal outcomes and to their child with respect to development later in life. The immune system plays a crucial role in major depression disorder (MDD), and studies indicate that both immune mediators (cytokines, chemokines) and neuroendocrine hormones cross-talk in MDD. However, the innate immune system is an unexplored field, and its link with prenatal depression has not been fully explored. The innate immune system is tightly regulated during early implantation and placentation of the conceptus, and such regulation is crucial for a successful pregnancy. T lymphocytes, which comprise helper T lymphocytes (Th), and cytotoxic T lymphocytes (CTLs), have been shown to be abundant at the fetomaternal interface together with the recruitment of different subsets of immune cells [Natural Killer cells (NK), Dendritic cells (DCs), Macrophages (MΦs)] during decidualization of the endometrium. Pregnancy is considered to be an inflammatory process in which a Th2 over a Th1 immune response is critical for allowing the development of the fetal allograft. Stressful stimuli and prenatal infections have been shown to deregulate the Th1/Th2 balance and are associated with increased production of proinflammatory cytokines and modification of neonatal immune responses via toll-like receptor (TLR) signaling. The innate immune system could represent a new frontier in exploring the etiology of several mental disorders, as suggested for schizophrenia. However, it is not clear how the innate immune system cross-talks with the fetal brain during perinatal depression.


  • Open Access

    Transplacental Transmission of Cutaneous Leishmania mexicana Strain in BALB/c Mice

    by Miroslava Avila-García, Javier Mancilla-Ramírez, Enrique Segura-Cervantes, Blanca Farfan-Labonne, Alicia Ramírez-Ramírez, Norma Galindo-Sevilla

    The vertical transmission of leishmaniasis has been reported in species that cause visceral leishmaniasis. However, this condition has scarcely been documented in species that cause cutaneous leishmaniasis. The aim of this study was to determine experimentally whether L. mexicana is transmitted vertically. A control group of BALB/c mice and a group infected with L. mexicana were mated, the gestation was monitored, and females were killed before delivery. Four resorptions (P = 0.023) and eight fetal deaths (P = 0.010) were observed in the infected female group; furthermore, the offspring body weight of the infected group was lower than the body weight of the healthy group (P = 0.009). DNA amplification by polymerase chain reaction (PCR) revealed that all placentas and maternal spleens as well as 39 of 110 fetal spleens obtained from the offspring of infected mothers tested positive for Leishmania. In conclusion, L. mexicana is transmitted transplacentally and causes fetal death, resorption, and reduction in offspring body weight.


  • Molecular studies of Onchocerca volvulus isolates from Mexico

    by Alicia Ramírez-Ramírez, Gustavo Sánchez-Tejeda, Jorge Méndez-Galván, Thomas R. Unnasch, Amalia Monroy-Ostria